Norges Bank’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.53B | Buy |
+3,958,856
| New | +$1.47B | 0.15% | 110 |
|
|
2026
Q1 | – | Sell |
-3,018,586
| Closed | -$1.06B | – | 442 |
|
|
2025
Q4 | $1.06B | Buy |
+3,018,586
| New | +$1.02B | 0.11% | 155 |
|
|
2025
Q3 | – | Sell |
-2,952,434
| Closed | -$1.15B | – | 497 |
|
|
2025
Q2 | $1.15B | Sell |
2,952,434
-35,733
| -1% | -$14.4M | 0.14% | 135 |
|
|
2025
Q1 | $1.3B | Sell |
2,988,167
-88,586
| -3% | -$35.6M | 0.18% | 110 |
|
|
2024
Q4 | $1.14B | Buy |
3,076,753
+100,591
| +3% | +$42.1M | 0.15% | 121 |
|
|
2024
Q3 | $1.55B | Sell |
2,976,162
-72,058
| -2% | -$38.5M | 0.22% | 85 |
|
|
2024
Q2 | $1.65B | Buy |
3,048,220
+328,416
| +12% | +$174M | 0.25% | 71 |
|
|
2024
Q1 | $1.41B | Sell |
2,719,804
-137,592
| -5% | -$68.4M | 0.22% | 81 |
|
|
2023
Q4 | $1.35B | Buy |
2,857,396
+271,714
| +11% | +$126M | 0.24% | 74 |
|
|
2023
Q3 | $1.13B | Buy |
2,585,682
+10,381
| +0.4% | +$4.71M | 0.23% | 79 |
|
|
2023
Q2 | $1.14B | Buy |
2,575,301
+79,307
| +3% | +$36.6M | 0.23% | 83 |
|
|
2023
Q1 | $1.15B | Buy |
2,495,994
+52,945
| +2% | +$25.2M | 0.25% | 77 |
|
|
2022
Q4 | $1.25B | Buy |
2,443,049
+158,748
| +7% | +$80.6M | 0.3% | 65 |
|
|
2022
Q3 | $1.04B | Buy |
2,284,301
+46,274
| +2% | +$22.1M | 0.28% | 70 |
|
|
2022
Q2 | $1.08B | Sell |
2,238,027
-73,800
| -3% | -$36.5M | 0.28% | 70 |
|
|
2022
Q1 | $1.14B | Sell |
2,311,827
-122,355
| -5% | -$55.9M | 0.25% | 76 |
|
|
2021
Q4 | $1.13B | Sell |
2,434,182
-42,558
| -2% | -$17.9M | 0.23% | 82 |
|
|
2021
Q3 | $923M | Sell |
2,476,740
-90,505
| -4% | -$34.4M | 0.2% | 94 |
|
|
2021
Q2 | $980M | Sell |
2,567,245
-134,988
| -5% | -$51.6M | 0.21% | 85 |
|
|
2021
Q1 | $970M | Buy |
2,702,233
+3,045
| +0.1% | +$979K | 0.22% | 81 |
|
|
2020
Q4 | $867M | Sell |
2,699,188
-16,015
| -0.6% | -$4.91M | 0.2% | 88 |
|
|
2020
Q3 | $729M | Sell |
2,715,203
-1,358
| -0% | -$365K | 0.19% | 92 |
|
|
2020
Q2 | $714M | Buy |
2,716,561
+215,118
| +9% | +$57.4M | 0.21% | 87 |
|
|
2020
Q1 | $568M | Sell |
2,501,443
-63,916
| -2% | -$17.4M | 0.2% | 93 |
|
|
2019
Q4 | $775M | Hold |
2,565,359
| – | – | 0.22% | 88 |
|
|
2019
Q3 | $616M | Hold |
2,565,359
| – | – | 0.19% | 98 |
|
|
2019
Q2 | $724M | Buy |
2,565,359
+25,570
| +1% | +$6.98M | 0.22% | 83 |
|
|
2019
Q1 | $729M | Sell |
2,539,789
-1,245
| -0% | -$360K | 0.24% | 81 |
|
|
2018
Q4 | $667M | Buy |
2,541,034
+74,299
| +3% | +$20.4M | 0.25% | 78 |
|
|
2018
Q3 | $676M | Sell |
2,466,735
-3,693
| -0.1% | -$959K | 0.22% | 87 |
|
|
2018
Q2 | $588M | Buy |
2,470,428
+59,469
| +2% | +$13.8M | 0.2% | 93 |
|
|
2018
Q1 | $530M | Sell |
2,410,959
-139,369
| -5% | -$32.7M | 0.19% | 107 |
|
|
2017
Q4 | $574M | Buy |
2,550,328
+28,708
| +1% | +$6.11M | 0.21% | 103 |
|
|
2017
Q3 | $479M | Hold |
2,521,620
| – | – | 0.18% | 116 |
|
|
2017
Q2 | $474M | Sell |
2,521,620
-47,136
| -2% | -$8.47M | 0.19% | 108 |
|
|
2017
Q1 | $425M | Sell |
2,568,756
-52,683
| -2% | -$8.38M | 0.17% | 115 |
|
|
2016
Q4 | $377M | Buy |
2,621,439
+81,419
| +3% | +$10.9M | 0.16% | 120 |
|
|
2016
Q3 | $304M | Hold |
2,540,020
| – | – | 0.14% | 133 |
|
|
2016
Q2 | $334M | Buy |
2,540,020
+102,678
| +4% | +$14M | 0.16% | 128 |
|
|
2016
Q1 | $339M | Sell |
2,437,342
-111,078
| -4% | -$14.8M | 0.17% | 121 |
|
|
2015
Q4 | $355M | Buy |
2,548,420
+122,896
| +5% | +$16.9M | 0.18% | 112 |
|
|
2015
Q3 | $340M | Sell |
2,425,524
-17,382
| -0.7% | -$2.61M | 0.18% | 112 |
|
|
2015
Q2 | $401M | Buy |
2,442,906
+55,535
| +2% | +$8.87M | 0.2% | 102 |
|
|
2015
Q1 | $369M | Buy |
2,387,371
+85,949
| +4% | +$12.2M | 0.18% | 110 |
|
|
2014
Q4 | $289M | Sell |
2,301,422
-26,805
| -1% | -$3.31M | 0.15% | 132 |
|
|
2014
Q3 | $279M | Sell |
2,328,227
-2,354,235
| -50% | -$270M | 0.15% | 136 |
|
|
2014
Q2 | $504M | Buy |
4,682,462
+2,341,231
| +100% | +$241M | 0.14% | 150 |
|
|
2014
Q1 | $233M | Hold |
2,341,231
| – | – | 0.13% | 153 |
|
|
2013
Q4 | $216M | Sell |
2,341,231
-282,004
| -11% | -$25.1M | 0.12% | 162 |
|
|
2013
Q3 | $219M | Hold |
2,623,235
| – | – | 0.13% | 155 |
|
|
2013
Q2 | $215M | Buy |
+2,623,235
| New | +$196M | 0.13% | 153 |
|
Other funds holding ELV
Norges Bank's ELV Position: Q2 2026 in Review
Norges Bank opened a new position in Elevance Health (ELV) in Q2 2026: 3,958,856 shares worth $1.53B. The stake represents 0.15% of the portfolio and ranks #110 among its holdings. This is a return to the name: Norges Bank previously reported a position in ELV as recently as Q4 2025.
Norges Bank first reported a position in ELV in Q2 2013 and has held it in 51 quarters since. The position peaked at $1.65B in Q2 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Norges Bank held 3,958,856 shares of Elevance Health worth $1.53B as of Q2 2026.
- Elevance Health was a new Norges Bank position in Q2 2026.
- Elevance Health made up 0.15% of Norges Bank's portfolio in Q2 2026, its #110 holding.
- Norges Bank first reported a position in Elevance Health in Q2 2013 and has held it in 51 quarters since.
- Norges Bank's Elevance Health position peaked at $1.65B in Q2 2024.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Norges Bank's 13F filing for Q2 2026, filed 12 Aug 2026.